Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Prostatic Neoplasms 12 Leukemia 12 Lymphoma 7 Burkitt Lymphoma 7 Leukemia, Biphenotypic, Acute 6 Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Lymphoma, Non-Hodgkin 4 Pituitary Neoplasms 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, B-Cell 3 Leukemia, Myeloid, Acute 3 Hodgkin Disease 3 Rhabdoid Tumor 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Obesity 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, T-Cell 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Follicular 2 Hematologic Neoplasms 2 Radiodermatitis 1 Pyloric Stenosis, Hypertrophic 1 Plasmablastic Lymphoma 1 Pituitary Diseases 1 Pinealoma 1

Interventions

Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lipomatosis, Multiple Symmetrical × Hydrocortisone × Clear all

NCT04821583 2021-03-29

N-of-1 SLN

Erasmus Medical Center

Phase 3 Unknown

Lipoma, Lipomatosis, Multiple Symmetrical

Data powered by HemOnc (CC BY 4.0) Colophon ⚡